Comparison of third-trimester indices in pregnant women with and without COVID-19 infection: A cross-sectional study
DOI:
https://doi.org/10.59692/jogeca.v37i2.368Keywords:
COVID 19 infection, pregnant women, third trimester, blood profileAbstract
Background: The third trimester represents a critical window in pregnancy when these hematologic changes could have the greatest impact. Therefore, understanding how coronavirus disease 2019 (COVID-19) infection influences blood profiles during this period is vital for clinical management and risk stratification. In Kenya, while national guidelines recommend laboratory evaluation, including complete blood count, c-reactive protein (CRP), lactate dehydrogenase (LDH), and coagulation profiles for pregnant women with suspected or confirmed COVID-19, there is a paucity of local data documenting these hematologic trends.
Objective: To investigate hematologic profile differences between pregnant women in the third trimester with and without COVID-19 infection.
Methods: A cross-sectional comparative study was employed to compare hematological parameters in pregnant women with and without
COVID-19 between May 1st and August 31st, 2021. We recruited 60 eligible patients from the Nairobi hospital using purposive sampling. We assessed the complete blood count, coagulation profile, lactate dehydrogenase, and C-reactive protein.
Results: Pregnant women with COVID-19 had significantly higher levels of neutrophils, prothrombin time, CRP, and LDH compared to those without, with respective AORs of 9.50 (p<0.01), 11.52 (p=0.001), and 3.06 (p=0.078). No significant differences were observed in white blood cells, basophils, and international normalized ratio after adjusting for age, parity, COVID-19 vaccination, and fetus number.
Conclusion: This study reported significant associations between neutrophil count, prothrombin time, CRP, LDH levels, and COVID-19 infection status in pregnant women. These indices may aid in distinguishing healthy pregnant women from those with COVID-19 infection.
Keywords: COVID-19 infection, pregnant women, third trimester, blood profile
References
Wilkinson M, Johnstone ED, Simcox LE, Myers JE. The impact of COVID-19 on pregnancy outcomes in a diverse cohort in England. Sci Rep. 2022;12(1):1–10.
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320.
Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014;370(23):2211–8.
Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental pathology in COVID-19. MedRxiv. 2023 Jul;5(7):10098.
Covali R, Socolov D, Socolov R, Brinzeu S, Grigoriu C, Gorduza EV, et al. Complete blood count peculiarities in pregnant SARS-CoV-2-infected patients at term: a cohort study. Diagnostics (Basel). 2021;12(1):70.
Vakili S, Savardashtaki A, Jamalnia S, Sadeghi M, Zarei SA, Mohamadkhani A, et al. Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: a literature review. Arch Med Res. 2020;51(7):603–7.
Kim JH, Shrestha N, Girshin M. Unexpected severe thrombocytopenia in the COVID-19 positive parturient. Anesth Analg. 2020;131(2):e116–7.
Zhang C, Chu H, Pei YV, Zhang J. Laboratory effects of COVID-19 infection in pregnant women and their newborns: a systematic review and meta-analysis. Front Glob Womens Health. 2021;2:684294.
Duffy CR, Hart JM, Modest AM, Powers E, Dizon AM, Dotters-Katz SK, et al. Lymphopenia and SARS-CoV-2 infection among hospitalized obstetric patients. Obstet Gynecol. 2020;136(2):229–31.
Zein JG, Strauss R, Attaway AH, Alqarzaee AA, Alshak MN, Sosnay PR, et al. Eosinophilia is associated with improved COVID-19 outcomes in inhaled corticosteroid-treated patients. J Allergy Clin Immunol Pract. 2022;10(3):742–50.e14.
Chen G, Liao Q, Ai J, Yang B, Bai H, Chen J, et al. Immune response to COVID-19 during pregnancy. Front Immunol. 2021;12:675476.
Hapshy V, Aziz D, Kahar P, Khanna D, Johnson KE, Parmar MS. COVID-19 and pregnancy: risk, symptoms, diagnosis, and treatment. SN Compr Clin Med. 2021;3(7):1477–83.
Servante J, Swallow G, Thornton JG, Huda T, Matata C, Bonet M, et al. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth. 2021;21(1):108.
Lombardi A, Duiella S, Piani LL, Bozzi G, Rescigno C, Ceriotti F, et al. Inflammatory biomarkers in pregnant women with COVID-19: a retrospective cohort study. Sci Rep. 2021;11(1):13350.
Sun G, Zhang Y, Liao Q, Cheng Y. Blood test results of pregnant COVID-19 patients: an updated case-control study. Front Cell Infect Microbiol. 2020;10:560899.
Bhowmik KK, Barek MA, Aziz MA, Islam MS. A systematic review and meta-analysis of abnormalities in hematological and biochemical markers among Bangladeshi COVID-19 cases. Health Sci Rep. 2022;5(4):e728.
Pinto V, Ranatunga K, Perera A, Abeyagunawardena M, Karunathilake D, Wijayaratne D, et al. Interim guidelines on management of COVID-19 ICU patients. Ministry of Health, Sri Lanka. 2020. Available from: https://anaesthesia.lk/wp-content/uploads/2020/05/GUIDELINES-ON-MANAGEMENT-OF-COVID-19-ICU-PATIENT-college-Copy.pdf
Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145–8.
Lippi G, Plebani M, Michael B. Thrombocytopenia in severe COVID-19 cases. Clin Chim Acta. 2020;506:145–8.
Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts critical illness in patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):206.
Liu H, Liu F, Li J, Zhang T, Wang D, Lan W. Clinical and CT imaging features of COVID-19 pneumonia: focus on pregnant women and children. J Infect. 2020;80(5):e7–e13.
Li N, Han L, Peng M, Lv Y, Ouyang Y, Liu K, et al. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study. Clin Infect Dis. 2020;71(16):2035–41.
Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of COVID-19 on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020;56(1):15–27.
Pereira A, Cruz-Melguizo S, Adrien M, Fuentes L, Marin E, Perez-Medina T. Clinical course of coronavirus disease-2019 in pregnancy. Acta Obstet Gynecol Scand. 2020;99(7):839–47.
Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033–40.
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–7.
Al-Saadi EAKD, Abdulnabi MA. Hematological changes associated with COVID-19 infection. J Clin Lab Anal. 2022;36(1):e24064.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 DANIEL OKETCH, Dr. Diana Ondieki, Prof. Ogutu O, Dr. James Amenge, Pamela Mandela, Kennedy Oduor
This work is licensed under a Creative Commons Attribution 4.0 International License.
